Incheon, South Korea

Mi Ji Lee



 

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Mi Ji Lee: Innovator in Polypeptide Complexes

Introduction

Mi Ji Lee is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of innovative protein complexes. With a total of five patents to his name, Lee's work focuses on enhancing the stability and efficacy of physiologically active polypeptides.

Latest Patents

One of Mi Ji Lee's latest patents involves a polypeptide complex comprising a non-peptidyl polymer with three functional ends. This innovative protein complex includes a physiologically active polypeptide, a dimeric protein, and a 3-arm non-peptidyl polymer. The unique design allows for the covalent bonding of both the physiologically active polypeptide and the dimeric protein to the polymer. This complex ensures long-acting activity and biostability of the polypeptide, significantly improving its serum half-life. The application of this technology can lead to the development of sustained release formulations for various physiologically active polypeptide drugs. Additionally, it utilizes raw materials efficiently, increasing production yield while allowing for easy purification.

Career Highlights

Mi Ji Lee is currently associated with Hanmi Science Co., Ltd., where he continues to push the boundaries of biopharmaceutical research. His work has garnered attention for its potential applications in drug development and therapeutic solutions.

Collaborations

Lee collaborates with notable colleagues, including Se Chang Kwon and Dae Hae Song, who contribute to the advancement of their shared research goals.

Conclusion

Mi Ji Lee's innovative work in polypeptide complexes showcases his commitment to enhancing drug efficacy and stability. His contributions are paving the way for future advancements in biopharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…